New methods for finding common insertion sites and co-occurring common insertion sites in transposon- and virus-based genetic screens
暂无分享,去创建一个
M. Steinbach | D. Largaespada | T. Starr | Haoyu Yu | T. Bergemann | R. Cormier | Kevin A. T. Silverstein | Yun Chen | Jesse Erdmann
[1] T. Scheetz,et al. A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. , 2009, Cancer research.
[2] Andrew I. Su,et al. The Gene Wiki: community intelligence applied to human gene annotation , 2009, Nucleic Acids Res..
[3] T. Suda,et al. Craniofacial malformation in R-spondin2 knockout mice. , 2009, Biochemical and biophysical research communications.
[4] Y. Asmann,et al. A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.
[5] Francesca Molinari,et al. PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. , 2009, Cancer research.
[6] Derek Y. Chiang,et al. A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma , 2009, Nature Biotechnology.
[7] R. Wang,et al. Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model , 2008, BMC Cancer.
[8] T. Hudson,et al. Germline EPHB2 Receptor Variants in Familial Colorectal Cancer , 2008, PloS one.
[9] J. Whitsett,et al. R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis , 2008, Development.
[10] T. Sugiura,et al. Protein phosphatase 1H, overexpressed in colon adenocarcinoma, is associated with CSE1L , 2008, Cancer biology & therapy.
[11] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[12] Andreas Prlic,et al. Ensembl 2008 , 2007, Nucleic Acids Res..
[13] W. Funk,et al. Mouse R-spondin2 is required for apical ectodermal ridge maintenance in the hindlimb. , 2007, Developmental biology.
[14] S. Rha,et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer , 2007, International journal of cancer.
[15] J. Fléjou,et al. Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer , 2007, International journal of cancer.
[16] C. Prives,et al. hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes , 2007, Cell.
[17] Marcel J. T. Reinders,et al. Co-occurrence analysis of insertional mutagenesis data reveals cooperating oncogenes , 2007, ISMB/ECCB.
[18] J. Kleibeuker,et al. Genotype-phenotype correlations as a guide in the management of familial adenomatous polyposis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[19] Marcel J. T. Reinders,et al. Detecting Statistically Significant Common Insertion Sites in Retroviral Insertional Mutagenesis Screens , 2006, PLoS Comput. Biol..
[20] J. A. Ferreira,et al. On the Benjamini-Hochberg method , 2006, math/0611265.
[21] A. Berns,et al. Retroviral insertional mutagenesis: past, present and future , 2005, Oncogene.
[22] Takeshi Oshima,et al. Mitogenic Influence of Human R-Spondin1 on the Intestinal Epithelium , 2005, Science.
[23] J. Ptak,et al. Colorectal cancer: Mutations in a signalling pathway , 2005, Nature.
[24] D. Largaespada,et al. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system , 2005, Nature.
[25] Corey M. Carlson,et al. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse , 2005, Nature.
[26] Carlo Rago,et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. , 2005, Cancer cell.
[27] M. Bertagnolli,et al. Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice* , 2004, Journal of Biological Chemistry.
[28] C. Niehrs,et al. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. , 2004, Developmental cell.
[29] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[30] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[31] Anton Berns,et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer , 2002, Nature Genetics.
[32] J. Monson,et al. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. , 2002, Anticancer research.
[33] R. Fodde. The APC gene in colorectal cancer. , 2002, European journal of cancer.
[34] A. Knudson,et al. Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.
[35] A. Harris,et al. Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[37] U. Scherf,et al. The hCSE1/CAS protein is phosphorylated by HeLa extracts and MEK-1: MEK-1 phosphorylation may modulate the intracellular localization of CAS. , 1998, Biochemical and biophysical research communications.
[38] R. Plasterk,et al. Molecular Reconstruction of Sleeping Beauty , a Tc1-like Transposon from Fish, and Its Transposition in Human Cells , 1997, Cell.
[39] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[40] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. J. Ashley,et al. The two "hit" and multiple "hit" theories of carcinogenesis. , 1969, British Journal of Cancer.
[42] M. Kimmel,et al. Conflict of interest statement. None declared. , 2010 .
[43] H. Clevers,et al. EphB/EphrinB receptors and Wnt signaling in colorectal cancer. , 2006, Cancer research.
[44] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[45] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .